ZBH
Zimmer Biomet Holdings Inc
NYSE: ZBH · HEALTHCARE · MEDICAL DEVICES
$80.07
-3.30% today
Updated 2026-04-29
Market cap
$15.50B
P/E ratio
20.74
P/S ratio
1.84x
EPS (TTM)
$3.86
Dividend yield
1.16%
52W range
$80 – $107
Volume
2.2M
Zimmer Biomet Holdings Inc (ZBH) Financial statements
SEC filings — annual and quarterly data.
Profit margin
9.05%
Operating margin
19.60%
ROE
6.07%
ROA
4.08%
Debt/equity
0.59x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $3.50B | $834.50M | 77.68% | 33.34% | 23.87% |
| 2007 | $3.90B | $773.20M | 77.53% | 28.93% | 19.84% |
| 2008 | $4.12B | $848.60M | 75.80% | 26.45% | 20.59% |
| 2009 | $4.10B | $717.40M | 75.81% | 24.88% | 17.52% |
| 2010 | $4.22B | $596.90M | 76.02% | 21.72% | 14.14% |
| 2011 | $4.45B | $760.80M | 74.80% | 23.00% | 17.09% |
| 2012 | $4.47B | $755.00M | 74.84% | 23.42% | 16.88% |
| 2013 | $4.62B | $761.00M | 72.18% | 22.40% | 16.46% |
| 2014 | $4.67B | $720.30M | 73.41% | 22.20% | 15.41% |
| 2015 | $6.00B | $147.00M | 69.98% | 7.79% | 2.45% |
| 2016 | $7.67B | $305.90M | 68.94% | 10.71% | 3.99% |
| 2017 | $7.80B | $1.81B | 72.67% | 10.24% | 23.24% |
| 2018 | $7.93B | $-379.20M | 71.36% | 0.43% | -4.78% |
| 2019 | $7.98B | $1.13B | 71.78% | 14.25% | 14.18% |
| 2020 | $6.13B | $-138.90M | 70.23% | 1.36% | -2.27% |
| 2021 | $6.83B | $401.60M | 71.29% | 12.60% | 5.88% |
| 2022 | $6.94B | $231.40M | 70.90% | 10.03% | 3.33% |
| 2023 | $7.39B | $1.02B | 71.82% | 17.28% | 13.85% |
| 2024 | $7.68B | $903.80M | 71.46% | 16.74% | 11.77% |
| 2025 | $8.23B | $705.20M | 61.62% | 16.55% | 8.57% |